Cholangiocarcinoma: all 930 studies
Page 2 of 10. Open to participants first (292), then studies with results posted, then the rest; newest registration first within each.
- The Dragon PLC Trial (DRAGON-PLC)RecruitingNCT06914648Not applicable
- Liver Transplantation for Locally Advanced Intrahepatic Cholangiocarcinoma After SIRT and ChemotherapyRecruitingNCT06910722Not applicable
- Neoadjuvant Tislelizumab, Gemcitabine, Cisplatin and S-1 for Resectable High-risk CholangiocarcinomaNot yet recruitingNCT06903273Phase 2
- Camrelizumab and Chemotherapy With or Without Anlotinib as First-line Treatment for Advanced Gallbladder Cancer and Extrahepatic CholangiocarcinomaEnrolling by invitationNCT06901622Phase 2
- Collection of Blood and Tissue Samples From Patients With Primary Liver Cancer.RecruitingNCT06899854
- HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver CancerRecruitingNCT06899152Not applicable
- Additional Chemotherapy Administered Directly Into the Liver Using a Chemo Pump in Patients With Bile Duct Cancer Inside the Liver Treatable by SurgeryRecruitingNCT06888063Phase 2
- On-treatment Surveillance of Tumor Evolution and Response to Systemic Treatment in Bile Duct and Liver CancerRecruitingNCT06877637
- A Simple Breath Test to Detect Liver Cancer and Monitor Liver ConditionsRecruitingNCT06864195
- Liver Transplantation for Unresectable Intrahepatic Colangiocarcinoma After Sustained Response to Neoadjuvant TreatmentsRecruitingNCT06862934
- Cryoablation Combined With Lenvatinib Plus Tislelizumab Compared With FOLFOX in Patients With Advanced Intrahepatic Cholangiocarcinoma (CASTLE-ZS-01)RecruitingNCT06860477Phase 2
- Hepatic Arterial Infusion Chemotherapy (HAIC) Combined With Durvalumab and Lenvatinib in Patients With Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma: a Phase 2 Study(HAIC-quad Trial)RecruitingNCT06859684Phase 2
- Phase II Clinical Study of GemOX Hepatic Arterial Infusion Combined with Lenvatinib and Toripalimab for Advanced and Unresectable Intrahepatic Cholangiocarcinoma and Gallbladder CancerRecruitingNCT06852287Phase 2
- Trop2-targeted immunoPET Imaging of Solid TumorsRecruitingNCT06851663Phase 2/3
- Novel Subtypes and Treatment Strategies of Patients with Unresectable Combined Hepatocellular Cholangiocarcinoma Based on Multimodal DataRecruitingNCT06849180
- A Study of PHST001 in Advanced Solid TumorsRecruitingNCT06840886Phase 1
- Validation of the Proteomic Profiling as a Diagnostic Test for Extra-hepatic CholangiocarcinomaNot yet recruitingNCT06780553
- Intra Artherial Therapies in Treatment of Primary Liver Diseases: an Observational StudyRecruitingNCT06774690
- In This Study, a Retrospective Analysis Was Conducted to Explore the Risk Factors for Patients Undergoing Pancreaticoduodenal Surgery (PD) to Achieve TO, and a Nomogram Prediction Model Was Further Established to Promote the Standardization and Standardization of PD Surgical Quality Evaluation.RecruitingNCT06763250
- Clinical Study of VG161 in Advanced Intrahepatic CholangiocarcinomaRecruitingNCT06746480Phase 2
- Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, BTC or NENRecruitingNCT06735560Not applicable
- Utidelone Capsule Monotherapy for Patients with Advanced Solid TumorsNot yet recruitingNCT06730581Phase 2
- A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or RearrangementRecruitingNCT06728410Phase 2
- A Study of MGC028 in Participants With Advanced Solid TumorsRecruitingNCT06723236Phase 1
- Toripalimab Combined With Gemcitabine and Cisplatin (GemCis) as Preoperative Neoadjuvant Therapy for Resectable Intrahepatic CholangiocarcinomaRecruitingNCT06721286Phase 2
- Robotically Assisted Surgery For Perihilar Cholangiocarcinoma: A Prospective StudyRecruitingNCT06720883
- Chemotherapy Combined with Immunotherapy and Targeted Therapy in CholangiocarcinomaRecruitingNCT06718257
- Spanish Registry of Digestive Tumours RETUDRecruitingNCT06711211
- Primary Percutaneous Stenting Above the Ampulla Versus Endoscopic Drainage for Unresectable Malignant Hilar Biliary ObstructionEnrolling by invitationNCT06671418Phase 3
- Spanish Registry of Quality Indicators and Adverse Events of Endoscopic Retrograde CholangiopancreatographyNot yet recruitingNCT06670547
- Exploring the Efficacy and Safety of Tislelizumab in Combination With S-1 in the Treatment of Patients With Postoperative Recurrent High-risk Intrahepatic CholangiocarcinomaRecruitingNCT06664021Phase 2
- A Novel Serological Risk Model for Early Non-invasive Diagnosis of CholangiocarcinomaNot yet recruitingNCT06658587
- Cell-Surface Plectin in the Diagnosis of Cholangiocarcinoma from ERCP-directed Biliary SamplesNot yet recruitingNCT06651346
- Adebrelimab Combined with Irinotecan Liposomes, 5-FU, CF ± Lenvatinib As First-line Treatment for Advanced ICCNot yet recruitingNCT06648525Phase 2
- Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus PembrolizumabRecruitingNCT06648057
- D-TACE-HAIC Combined With Envafolimab and Lenvatinib for Unresectable ICCRecruitingNCT06643208
- D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract CancerRecruitingNCT06622057Phase 3
- Ivosidenib in Locally Advanced or Metastatic Cholangiocarcinoma With IDH1 R132 Mutation After at Least One Prior Systemic Treatment - an Observational StudyRecruitingNCT06607302
- Phase 2 Trial of Adjuvant Adebrelimab Combined With Capecitabine in High-Risk Resected Cholangiocarcinoma: ACHIEVERecruitingNCT06607276Phase 2
- A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4α srRNA in Treating Advanced ICC PatientsRecruitingNCT06583993Early Phase 1
- Gemcitabine/Cisplatin/Nab-Paclitaxel and Rilvegostomig in Resectable iCCANot yet recruitingNCT06569225Phase 2
- Low-dose Gemcitabine and Cisplatin and PD-1/PD-L1 Antibody Therapy in Intrahepatic CholangiocarcinomaNot yet recruitingNCT06567600Phase 2
- Chemoimmunotherapy Combined With Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract CancerRecruitingNCT06546969Phase 1
- A French Multicenter Observational Retrospective Study of Rare Primary Liver CancersRecruitingNCT06541652
- Living Donor Liver Transplantation for Intrahepatic CholangiocarcinomaNot yet recruitingNCT06539377Not applicable
- Impact of Preoperative Endoscopic Ultrasound-guided Fine-needle Aspiration in Cholangiocarcinoma PatientsNot yet recruitingNCT06534229
- Pemigatinib Combined With Durvalumab for Previously Treated Biliary Tract CarcinomaNot yet recruitingNCT06530823Phase 2
- Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer PatientsRecruitingNCT06529718Phase 2
- GEMOX-HAIC Plus GEM-SYS in Combination With Lenvatinib and PD-1 Inhibitor for Large Unresectable ICCRecruitingNCT06505486
- 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer DetectionRecruitingNCT06503146Phase 2
- Phase 2 Study: OBI-833/OBI-821 Maintenance for Globo H+ Advanced Biliary Tract Cancer After Gemcitabine/CisplatinNot yet recruitingNCT06490198Phase 1
- TACE Combined With Immune Checkpoint Inhibitors for Liver Malignant TumorsRecruitingNCT06487663Not applicable
- Liquid Biopsy MonitORing Of CholangioCarcinOma for Treatment Response and Prognostic Outcomes (MOROCCO)Enrolling by invitationNCT06474091
- Microwave Ablation Versus Liver Resection for Intrahepatic CholangiocarcinomaRecruitingNCT06462742
- Phase II Study of the Combination of Durvalumab (MEDI4736) (PDL1 Inhibitor) and Olaparib (PARP Inhibitor) in Advanced Cholangiocarcinoma After Initial Chemotherapy and Durvalumab (BIL-PPP)RecruitingNCT06441747Phase 2
- Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extra- and Intrahepatic CholangiocarcinomaRecruitingNCT06440993Phase 2
- INSPIRE: a Multi-Cancer Early Detection StudyRecruitingNCT06440018
- Cadonilimab Combined With Liposomal Irinotecan Plus Leucovorin and Fluorouracil for Advanced CholangiocarcinomaRecruitingNCT06438822Phase 2
- Evaluation of Combined Modality Protons and Hepatic Transplantation for Hilar CholangiocarcinomaNot yet recruitingNCT06434493Not applicable
- Lenvatinib and Adebrelimab Combined With GEMOX in the Perioperative Treatment of Potentially Resectable Intrahepatic CholangiocarcinomaNot yet recruitingNCT06417606Phase 4
- Diagnostic Approach for Cholangiocarcinoma Using Liquid Bile BiopsyRecruitingNCT06416397
- Neoantigen Vaccine Plus Capecitabine as Adjuvant Therapy for Intrahepatic Cholangiocarcinoma After Radical ResectionRecruitingNCT06406816Early Phase 1
- Precision Medicine in Patients With Unresectable CholAngiocarcinoma: RadioEmbolization and Combined Biological TherapyRecruitingNCT06375915Phase 2
- A Single Arm, Single Centered Phase II Trial on the Combination of Adebrelimab, Surufatinib and Irinotecan Liposome-based HAIC in Advanced iCCNot yet recruitingNCT06375642Phase 2
- Rollover Study to Provide Continued Access to TT-00420 (Tinengotinib) for Subjects With Advanced Solid TumorsAvailableNCT06370013
- Digital Single-operator Cholangioscopy and Intraductal Ultrasound for Nonicteric Biliary StricturesNot yet recruitingNCT06369896
- Prognostic Factors for Survival in Patients With CholangiocarcinomaRecruitingNCT06369480
- Plasma Metabolic Biomarkers for Multi-Cancer DiagnosisRecruitingNCT06363123
- The Effect of [18F] F-FAPI PET-CT on Management in Patients With Proximal CholangiocarcinomaRecruitingNCT06355427Phase 2/3
- An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver CancerRecruitingNCT06342414
- Neo-adjuvant Chemo and Immunotherapy in the Pre-operAtive Treatment of Locally Advanced CholangIOcarciNomaRecruitingNCT06341764Phase 2
- Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)RecruitingNCT06340646Not applicable
- HAIC Combined With Cadonilimab and Regorafenib as 2nd-line Treatment for ICCRecruitingNCT06335927Phase 2
- Surufatinib Combined With Toripalimab and HAIC in the Treatment of Inoperable or Metastatic Intrahepatic CholangiocarcinomaNot yet recruitingNCT06313554Not applicable
- HAI-Floxuridine, or SIRT, Combined With Gemox For Patients With Intra-Hepatic Cholangiocarcinoma Not Amenable to Resection (TOMCAT)RecruitingNCT06313203Phase 2
- Open Versus Laparoscopic Ablation of Liver MalignanciesRecruitingNCT06304766Not applicable
- Pemigatinib + Afatinib in Advanced Refractory Solid TumorsRecruitingNCT06302621Phase 1
- Combined Therapy Using Gemcitabine and Cisplatin Chemotherapy, Lenvatinib and Adebrelimab for Patients With Advanced and Unresectable Intrahepatic CholangiocarcinomaRecruitingNCT06298968Phase 2
- Perioperative Treatment of Resectable Intrahepatic Cholangiocarcinoma With the Combination of Adebrelimab and Apatinib and HAICRecruitingNCT06296563Phase 2
- Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract CancerRecruitingNCT06282575Phase 3
- Chemotherapy Combined With Adebrelimab and Apatinib as the Perioperative Treatment in Patients With Biliary Tract CancerRecruitingNCT06280508Phase 2
- Evaluation of diagnostiC Capacity of eccDNAs as Biomarkers in Indetermined biLiary Stricture(ECCBILE)RecruitingNCT06277531
- A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid TumorsRecruitingNCT06270706Phase 1
- Targeted Navigation in Hepatocellular Carcinoma (HCC)RecruitingNCT06260943Not applicable
- Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid TumorsRecruitingNCT06256055Phase 1
- Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid TumorsRecruitingNCT06239194Phase 1/2
- Neoadjuvant Therapy of HAIC（GEMOX） Combined With Adebrelimab and Lenvatinib for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence FactorsRecruitingNCT06208462Phase 2
- Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast CancerRecruitingNCT06199895Phase 2
- Early Phase I Study of Autologous T Cells (EX02 CAR-T) for Unresectable Pancreatic/Bile Duct CancerNot yet recruitingNCT06196658Early Phase 1
- DEB-TACE, Lenvatinib and Anti-PD(L)1 Antibody as Conversion Therapy for Intrahepatic CholangiocarcinomaRecruitingNCT06194695
- Combined HAIC, Lenvatinib and Pucotenlimab as Conversion Therapy for Unresectable Intrahepatic CholangiocarcinomaRecruitingNCT06192797Phase 2
- Combined DEB-TACE, Lenvatinib and Pucotenlimab as Conversion Therapy for Unresectable Intrahepatic CholangiocarcinomaRecruitingNCT06192784Phase 2
- Endoscopic Radiofrequency Ablation for Unresectable CholangiocarcinomaRecruitingNCT06175845Not applicable
- Intraductal Radiofrequency Thermoablation and Radiotherapy Combined Treatment for Extrahepatic CholangiocarcinomaRecruitingNCT06168292Not applicable
- Precision Medicine for Combined Hepatocellular-CholangiocarcinomaRecruitingNCT06146127
- Liver Transplantation in Intrahepatic CholangiocarcinomaRecruitingNCT06140134
- Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract CancerNot yet recruitingNCT06134193Phase 2
- Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes（CAR-T） for CEA Positive Advanced Malignant Solid TumorsRecruitingNCT06126406Phase 1
- Endoscopic Scissors Cutting Nasobiliary Duct VS Bilateral Plastic StentRecruitingNCT06106750Not applicable
- Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)RecruitingNCT06101277Not applicable